Etanercept(CAS: 185243-69-0)

Etanercept (CAS: 185243-69-0) is a protein-based medication used to treat various autoimmune diseases and inflammatory conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. It is composed of a human tumor necrosis factor (TNF) receptor fused to the Fc region of human IgG1.

Etanercept (CAS: 185243-69-0) is primarily used for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and juvenile idiopathic arthritis. It works by blocking the action of TNF, a protein involved in the inflammatory response.

Etanercept (CAS: 185243-69-0) is considered generally safe when used as directed. However, like all medications, it may cause side effects such as injection site reactions, infections, and allergic reactions. It is important to follow the prescribed dosage and consult a healthcare provider if any adverse effects are experienced.

Etanercept (CAS: 185243-69-0) should be stored refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and keep the vial sealed until ready to use. After reconstitution, the product should be used immediately or stored in a refrigerator and used within 28 days.